메뉴 건너뛰기




Volumn 22, Issue SUPPL., 2007, Pages

Retrospective analysis of peripheral blood stem cell transplantation for the treatment of high-risk neuroblastoma

Author keywords

Autologous transplantation; Neuroblastoma; Peripheral blood stem cell transplantation

Indexed keywords


EID: 36148951713     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.s.s66     Document Type: Article
Times cited : (9)

References (37)
  • 15
    • 0031431540 scopus 로고    scopus 로고
    • Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry
    • Lode HN, Handgretinger R, Schuermann U, Seitz G, Klingebiel T, Niethammer D, Beck J. Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer 1997; 33: 2024-30.
    • (1997) Eur J Cancer , vol.33 , pp. 2024-2030
    • Lode, H.N.1    Handgretinger, R.2    Schuermann, U.3    Seitz, G.4    Klingebiel, T.5    Niethammer, D.6    Beck, J.7
  • 19
    • 0344654819 scopus 로고    scopus 로고
    • Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level
    • Hafer R, Voigt A, Gruhn B, Zintl F. Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level. J Neuroimmunol 1999; 96: 201-6.
    • (1999) J Neuroimmunol , vol.96 , pp. 201-206
    • Hafer, R.1    Voigt, A.2    Gruhn, B.3    Zintl, F.4
  • 32
    • 0027980190 scopus 로고
    • Interleukin-2: Solid-tumor therapy
    • Oppenheim MH, Lotze MT. Interleukin-2: solid-tumor therapy. Oncology 1994; 51: 154-69.
    • (1994) Oncology , vol.51 , pp. 154-169
    • Oppenheim, M.H.1    Lotze, M.T.2
  • 33
    • 10344265995 scopus 로고    scopus 로고
    • High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: Pilot study
    • Pardo N, Marti F, Fraga G, Illa J, Badell I, Peiro M, Bertran E, Garcia J, Rueda F, Cubells J. High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study. Med Pediatr Oncol 1996; 27: 534-9.
    • (1996) Med Pediatr Oncol , vol.27 , pp. 534-539
    • Pardo, N.1    Marti, F.2    Fraga, G.3    Illa, J.4    Badell, I.5    Peiro, M.6    Bertran, E.7    Garcia, J.8    Rueda, F.9    Cubells, J.10
  • 35
    • 36148951096 scopus 로고    scopus 로고
    • Effects of low dose interleukin-2 therapy after high dose chemotherapy and autologous PBSCT in childhood AML and stage 4 neuroblastoma
    • Kim MK, Lyu CJ, Park SH, Cho HS, Yang CH, Kim HM, Kang SH, Kim KY. Effects of low dose interleukin-2 therapy after high dose chemotherapy and autologous PBSCT in childhood AML and stage 4 neuroblastoma. Korean J Pediatr Hematol-Oncol 2000; 7: 82-91.
    • (2000) Korean J Pediatr Hematol-Oncol , vol.7 , pp. 82-91
    • Kim, M.K.1    Lyu, C.J.2    Park, S.H.3    Cho, H.S.4    Yang, C.H.5    Kim, H.M.6    Kang, S.H.7    Kim, K.Y.8
  • 36
    • 0029039308 scopus 로고
    • A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study
    • Bauer M, Reaman GH, Hank JA, Cairo MS, Anderson P, Blazar BR, Frierdich S, Sondel PM. A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study. Cancer 1995; 75: 2959-65.
    • (1995) Cancer , vol.75 , pp. 2959-2965
    • Bauer, M.1    Reaman, G.H.2    Hank, J.A.3    Cairo, M.S.4    Anderson, P.5    Blazar, B.R.6    Frierdich, S.7    Sondel, P.M.8
  • 37
    • 0343851075 scopus 로고    scopus 로고
    • Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients
    • Vlk V, Eckschlager T, Kavan P, Kabickova E, Koutecky J, Sobota V, Bubenik J, Pospisilova D. Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients. Pediatr Hematol Oncol 2000; 17: 31-44.
    • (2000) Pediatr Hematol Oncol , vol.17 , pp. 31-44
    • Vlk, V.1    Eckschlager, T.2    Kavan, P.3    Kabickova, E.4    Koutecky, J.5    Sobota, V.6    Bubenik, J.7    Pospisilova, D.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.